How to buy Tilray stock | 5.56

Tilray, Inc is a drug manufacturers—specialty & generic business based in the US. Tilray shares (TLRY) are listed on the NASDAQ and all prices are listed in US Dollars. Tilray employs 1,646 staff and has a trailing 12-month revenue of around USD$184.1 million.

How to buy shares in Tilray

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Tilray. Find the stock by name or ticker symbol: TLRY. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tilray reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$5.56, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Tilray, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Tilray. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Tilray's share price?

Since the stock market crash in March caused by coronavirus, Tilray's share price has had significant negative movement.

Its last market close was USD$5.56, which is 71.30% down on its pre-crash value of USD$19.37 and 128.81% up on the lowest point reached during the March crash when the shares fell as low as USD$2.43.

If you had bought USD$1,000 worth of Tilray shares at the start of February 2020, those shares would have been worth USD$223.07 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$322.15.

Tilray share price

Use our graph to track the performance of TLRY stocks over time.

Tilray shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	USD$5.56
52-week range	USD$2.43 - USD$25.685
50-day moving average	USD$5.5191
200-day moving average	USD$7.2242
Wall St. target price	USD$7.77
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.23

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Tilray stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Tilray, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tilray price performance over time

Historical closes compared with the close of $5.56 from 2020-10-16

1 week (2020-10-22)	-18.59%
1 month (2020-09-29)	15.11%
3 months (2020-07-29)	-26.16%
6 months (2020-04-29)	-31.44%

1 year (2019-10-29)	-74.90%
2 years (2018-10-29)	-93.87%
3 years (2017-10-25)	N/A
5 years (2015-10-25)	N/A

Tilray financials

Revenue TTM	USD$184.1 million
Gross profit TTM	USD$-21,455,000
Return on assets TTM	-15.52%
Return on equity TTM	-212.06%
Profit margin	-283.2%
Book value	$1.044
Market capitalisation	USD$852.7 million

TTM: trailing 12 months

Shorting Tilray shares

There are currently 23.8 million Tilray shares held short by investors – that's known as Tilray's "short interest". This figure is 39.3% up from 17.1 million last month.

There are a few different ways that this level of interest in shorting Tilray shares can be evaluated.

Tilray's "short interest ratio" (SIR)

Tilray's "short interest ratio" (SIR) is the quantity of Tilray shares currently shorted divided by the average quantity of Tilray shares traded daily (recently around 5.5 million). Tilray's SIR currently stands at 4.32. In other words for every 100,000 Tilray shares traded daily on the market, roughly 4320 shares are currently held short.

However Tilray's short interest can also be evaluated against the total number of Tilray shares, or, against the total number of tradable Tilray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tilray's short interest could be expressed as 0.18% of the outstanding shares (for every 100,000 Tilray shares in existence, roughly 180 shares are currently held short) or 0.19% of the tradable shares (for every 100,000 tradable Tilray shares, roughly 190 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tilray.

Find out more about how you can short Tilray stock.

Tilray share dividends

We're not expecting Tilray to pay a dividend over the next 12 months.

Tilray share price volatility

Over the last 12 months, Tilray's shares have ranged in value from as little as $2.43 up to $25.685. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 3.0022. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Tilray overview

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.

Frequently asked questions

• What percentage of Tilray is owned by insiders or institutions?

  Currently 67.041% of Tilray shares are held by insiders and 13.956% by institutions.

• How many people work for Tilray?

  Latest data suggests 1,646 work at Tilray.

• When does the fiscal year end for Tilray?

  Tilray's fiscal year ends in December.

• Where is Tilray based?

  Tilray's address is: 1100 Maughan Road, Nanaimo, BC, Canada, V9X IJ2

• What is Tilray's CUSIP number?

  Tilray's Committee on Uniform Securities Identification Procedures number is: 88688T100